ChenGuang Biotech Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	1,802	1,422	1,147	732.59
Short-Term Investments	-	14.01	17.02	13.75	5.07
Trading Asset Securities	-	8.13	79.85	17.58	0.56
Cash & Short-Term Investments	2,141	1,825	1,519	1,178	738.22
Cash Growth	17.36%	20.09%	28.98%	59.57%	136.70%
Accounts Receivable	-	458.39	474.39	311.4	398.77
Other Receivables	-	9.54	17.17	77.56	12.63
Receivables	-	467.93	491.56	388.96	411.4
Inventory	-	3,862	3,198	2,033	2,229
Prepaid Expenses	-	-	-	1.48	0.01
Other Current Assets	-	654.03	1,157	1,325	598.8
Total Current Assets	-	6,809	6,367	4,927	3,977
Property, Plant & Equipment	-	1,663	1,696	1,538	1,484
Long-Term Investments	-	112.71	101.47	92.25	173.01
Goodwill	-	0.59	0.59	0.59	0.59
Other Intangible Assets	-	337.01	304.19	308.9	265.71
Long-Term Deferred Tax Assets	-	56.56	44.39	35.79	31.54
Long-Term Deferred Charges	-	8.88	12.63	6.75	3.93
Other Long-Term Assets	-	35.21	13.89	14.32	19.83
Total Assets	-	9,023	8,540	6,924	5,955
Accounts Payable	-	153.85	79.53	55.96	36.09
Accrued Expenses	-	117.52	122.58	146.93	105.49
Short-Term Debt	-	2,304	2,599	2,043	1,839
Current Portion of Long-Term Debt	-	1,537	750.56	0.62	300.52
Current Portion of Leases	-	0.23	0.22	0.21	0.06
Current Income Taxes Payable	-	18.82	41.16	41.82	18.22
Current Unearned Revenue	-	335.29	236.04	365.61	307.91
Other Current Liabilities	-	129.88	123.01	102.82	75.03
Total Current Liabilities	-	4,596	3,952	2,757	2,682
Long-Term Debt	-	1,068	865	770	303.1
Long-Term Leases	-	3.56	3.79	4	2.67
Long-Term Unearned Revenue	-	150.44	117.72	93.69	83.6
Long-Term Deferred Tax Liabilities	-	14.7	16.57	16.64	14.56
Other Long-Term Liabilities	-	35.12	52.23	68.08	85.79
Total Liabilities	-	5,868	5,007	3,710	3,172
Common Stock	-	483.1	532.77	532.77	532.77
Additional Paid-In Capital	-	581.98	1,022	1,022	1,025
Retained Earnings	-	2,085	2,056	1,662	1,294
Treasury Stock	-	-	-95.84	-	-
Comprehensive Income & Other	-	-40.87	-44.2	-51.43	-67.2
Total Common Equity	3,335	3,109	3,470	3,165	2,785
Minority Interest	-	45.2	61.79	49.26	-2.1
Shareholders' Equity	3,387	3,155	3,532	3,214	2,783
Total Liabilities & Equity	-	9,023	8,540	6,924	5,955
Total Debt	3,842	4,912	4,218	2,818	2,445
Net Cash (Debt)	-1,701	-3,088	-2,699	-1,640	-1,707
Net Cash Per Share	-3.57	-5.97	-5.07	-3.08	-3.23
Filing Date Shares Outstanding	456.85	483.1	532.77	532.77	532.77
Total Common Shares Outstanding	483.1	483.1	532.77	532.77	532.77
Working Capital	-	2,213	2,415	2,170	1,295
Book Value Per Share	6.90	6.44	6.51	5.94	5.23
Tangible Book Value	3,001	2,772	3,166	2,855	2,519
Tangible Book Value Per Share	6.21	5.74	5.94	5.36	4.73
Buildings	-	968.65	865.58	-	709.91
Machinery	-	1,549	1,359	-	1,139
Construction In Progress	-	112.43	295.48	-	219.84

Source: S&P Global Market Intelligence. Standard template. Financial Sources.